Canopy Growth Corporation (WEED.TO)
| Previous close | 31.56 |
| Open | 31.82 |
| Bid | 31.20 x 0 |
| Ask | 31.21 x 0 |
| Day's range | 30.80 - 31.83 |
| 52-week range | 18.34 - 71.60 |
| Volume | 1,030,965 |
| Avg. volume | 1,414,658 |
| Market cap | 11.963B |
| Beta (5Y monthly) | 2.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.43 |
| Earnings date | 01 Jun 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 39.07 |
- Yahoo Finance
Psychedelic drugmaker MindMed stumbles in Nasdaq debut, CEO says 'still very early innings'
MindMed’s Nasdaq debut Tuesday made it the second psychedelic drug developer to be listed on a major U.S. stock exchange.
- PR Newswire
Canopy Growth Signs U.S. Distribution Agreement with Southern Glazer's Wine & Spirits for CBD Beverage Portfolio
Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer's Wine & Spirits ("Southern Glazer's"), the world's pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau – Canopy's first line of CBD-infused beverages sold in the U.S market.
- Yahoo Finance Video
The road to federal cannabis legalization
Vivien Azer, Cowen Managing Director and Senior Research Analyst joins the Yahoo Finance Live panel to discuss the wave of state level legalizations and the future of the cannabis industry.
